化合物M2698 T11928
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mg | 1379545-95-5 | ¥728.00 | 询底价 |
1 mL | 1379545-95-5 | ¥2,080.00 | 询底价 |
100 mg | 1379545-95-5 | ¥9,330.00 | 询底价 |
50 mg | 1379545-95-5 | ¥6,890.00 | 询底价 |
10 mg | 1379545-95-5 | ¥2,890.00 | 询底价 |
5 mg | 1379545-95-5 | ¥1,820.00 | 询底价 |
25 mg | 1379545-95-5 | ¥4,850.00 | 询底价 |
Product Introduction
Bioactivity
英文名: M2698
描述: M2698 (MSC2363318A) 是 p70S6K、Akt1 和 Akt3 的抑制剂,IC50 为 1 nM。 M2698 显示出抗癌活性。
体外活性: M2698 (0.3 nM-50 M) dose-dependently inhibits proliferation in breast tumor cell lines (IC50s: 0.02-8.5 µM). M2698 (0.3-1 µM) induces feedback loop phosphorylation on Akt and suppresses Akt and p70S6K activity in HCC1419 and MDA-MB-453 cells. M2698 inhibits indirectly pGSK3β and pS6 with IC50s of 17 and 15 nM[1].
体内活性: Gavage administration of M2698 (10-30 mg/kg) dose-dependently inhibits the growth of tumors and increases pAkt levels in tumor tissue. M2698 (30 mg/kg) causes tumor regression. M2698 (1-20 mg/kg) inhibits S6 phosphorylation in a dose-proportional manner over time[1].
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 112.5 mg/mL (250.1 mM)
关键字: M 2698 | M-2698 | M2698
相关产品: ML-9 | LM22B-10 | DB07107 | 3β-Methoxy-2,3-dihydrowithaferin A | Ipfencarbazone | Alphitolic acid | N-Feruloyloctopamine | MKC-1 | 3,4,5-Tricaffeoylquinic acid | Patritumab
相关库: Antioxidant Compound Library | Drug Repurposing Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Anti-Cancer Clinical Compound Library | Inhibitor Library | Kinase Inhibitor Library | Cytoskeletal Signaling Pathway Compound Library | Anti-Cancer Active Compound Library | Bioactive Compound Library
化合物M2698 T11928信息由TargetMol中国为您提供,如您想了解更多关于化合物M2698 T11928报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途